Skip to main content
Clinical Trials/RPCEC00000289
RPCEC00000289
Not yet recruiting
Phase 3

Comparative study of the efficacy and safety of topic OLEOZON, Ketoconazole and Terbinafine in patients with epidermophytosis.

ational Center For Scientific Research0 sites300 target enrollmentSeptember 28, 2018

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Epidermophytosis
Sponsor
ational Center For Scientific Research
Enrollment
300
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 28, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Center For Scientific Research

Eligibility Criteria

Inclusion Criteria

  • Patients greater than or equal to 18 years, of both sexes, who have signed their informed consent to participate in the study, with clinical diagnosis and positive mycological diagnosis of tinea pedis variety squamous, in addition patients without other infection added, virgin of treatments or with more than five days without treatment Specific topical or systemic.

Exclusion Criteria

  • Decompensated diabetes mellitus (fasting glucose\> 7 mmol/L), diagnosed neoplasms, severe septic states, history of liver failure, history of renal failure, chronic diseases, pregnancy, concomitant use of corticosteroids, cytostatics or immunosuppressants and antibiotics, clinical history usual allergy to medications or any other special condition that at the discretion of the doctor puts your health and life at risk during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials